CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-18 | Ali-Jackson Kamil Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −1,075 | 3,225 | ||
| 2016-12-18 | Walker Neal President and CEO | Exercise or conversion | +2,925 | 874,908 | ||
| 2016-12-18 | Walker Neal President and CEO | Shares withheld for taxes | −889 | $31.25 | $28K | 874,019 |
| 2016-12-18 | Walker Neal President and CEO | Exercise or conversion · Restricted Stock Units | −2,925 | 8,775 | ||
| 2016-12-18 | Shanler Stuart Chief Scientific Officer | Exercise or conversion | +1,450 | 262,319 | ||
| 2016-12-18 | Shanler Stuart Chief Scientific Officer | Shares withheld for taxes | −441 | $31.25 | $14K | 261,878 |
| 2016-12-18 | Shanler Stuart Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,450 | 4,350 | ||
| 2016-12-15 | Shanler Stuart Chief Scientific Officer | Grant or award · Stock option (right to buy) | +62,400 | 62,400 | ||
| 2016-12-15 | Shanler Stuart Chief Scientific Officer | Grant or award · Restricted stock units | +10,400 | 10,400 | ||
| 2016-12-15 | Powala Christopher Chief Operating Officer | Grant or award · Stock option (right to buy) | +62,400 | 62,400 | ||
| 2016-12-15 | Powala Christopher Chief Operating Officer | Grant or award · Restricted stock units | +10,400 | 10,400 | ||
| 2016-12-15 | Ruffo Frank Chief Financial Officer | Grant or award · Stock option (right to buy) | +62,400 | 62,400 | ||
| 2016-12-15 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +10,400 | 10,400 | ||
| 2016-12-15 | Walker Neal President and CEO | Grant or award · Stock option (right to buy) | +145,600 | 145,600 | ||
| 2016-12-15 | Walker Neal President and CEO | Grant or award · Restricted stock units | +24,266 | 24,266 | ||
| 2016-12-15 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Stock option (right to buy) | +83,200 | 83,200 | ||
| 2016-12-15 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Restricted stock units | +13,866 | 13,866 | ||
| 2016-11-18 | VIVO VENTURES VII, LLC 10% owner | Sale | −440,402 | $22.72 | $10.0M | 3,213,532 |
| 2016-11-18 | VIVO VENTURES VII, LLC 10% owner | Sale | −9,598 | $22.72 | $218K | 70,037 |
| 2016-11-16 | VIVO VENTURES VII, LLC 10% owner | Sale | −448,063 | $23.25 | $10.4M | 3,653,934 |
Page 51 of 57 · 1,130 trades